Gyre Therapeutics's total assets for Q1 2025 were $129.79M, an increase of 3.50% from the previous quarter. GYRE total liabilities were $25.49M for the fiscal quarter, a -5.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.